Bonine
FDA Label NDC 65197-616

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Wellspring Pharmaceutical Corporation for the product Bonine (NDC 65197-616). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding bonine- diphenhydramine hcl - tabletwellspring pharmaceutical corporationdisclaimer: most otc drugs are not reviewed and approved by fda, however they may be marketed if they comply with applicable regulations and policies. fda has not evaluated whether this product complies., active ingredient (in each tablet), purpose, uses, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.